Vermillion Net Income 2006-2019 | VRML

Vermillion net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Vermillion Annual Net Income
(Millions of US $)
2018 $-11
2017 $-11
2016 $-15
2015 $-19
2014 $-19
2013 $-9
2012 $-7
2011 $-18
2010 $-19
2009 $-22
2008 $-18
2007 $-21
2006 $-22
2005 $-35
Vermillion Quarterly Net Income
(Millions of US $)
Q3 2019 $-4
Q2 2019 $-4
Q1 2019 $-4
Q4 2018 $-3
Q3 2018 $-3
Q2 2018 $-3
Q1 2018 $-3
Q4 2017 $-3
Q3 2017 $-3
Q2 2017 $-2
Q1 2017 $-3
Q4 2016 $-3
Q3 2016 $-3
Q2 2016 $-4
Q1 2016 $-5
Q4 2015 $-5
Q3 2015 $-5
Q2 2015 $-5
Q1 2015 $-4
Q4 2014 $-4
Q3 2014 $-6
Q2 2014 $-6
Q1 2014 $-4
Q4 2013 $-2
Q3 2013 $-2
Q2 2013 $-2
Q1 2013 $-3
Q4 2012 $-1
Q3 2012 $-2
Q2 2012 $-2
Q1 2012 $-2
Q4 2011 $-3
Q3 2011 $-5
Q2 2011 $-6
Q1 2011 $-4
Q4 2010 $-4
Q3 2010 $-3
Q2 2010 $-1
Q1 2010 $-12
Q4 2009 $-6
Q3 2009 $-11
Q2 2009 $-2
Q1 2009 $-3
Q4 2008 $-4
Q3 2008 $-5
Q2 2008 $-4
Q1 2008 $-5
Q4 2007 $-3
Q3 2007 $-5
Q2 2007 $-7
Q1 2007 $-6
Q4 2006 $-2
Q3 2006 $-7
Q2 2006 $-8
Q1 2006 $-5
Q4 2005 $-10
Q3 2005 $-7
Q2 2005 $-9
Q1 2005 $-9
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.073B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $126.569B 26.22
Intuitive Surgical (ISRG) United States $67.302B 52.89
Edwards Lifesciences (EW) United States $51.348B 46.63
Fresenius Medical Care AG KGaA (FMS) Germany $22.203B 15.02
IDEXX Laboratories (IDXX) United States $21.605B 52.25
DexCom (DXCM) United States $20.977B 187.85
Olympus (OCPNY) Japan $20.547B 154.31
Teleflex (TFX) United States $16.371B 33.23
Sysmex ADR (SSMXY) Japan $14.806B 39.85
SONOVA HOLDING (SONVY) Switzerland $14.332B 0.00
Hologic (HOLX) United States $13.981B 21.37
STERIS (STE) Ireland $13.063B 28.85
Varian Medical Systems (VAR) United States $12.593B 29.86
ABIOMED (ABMD) United States $8.755B 47.64
Masimo (MASI) United States $8.394B 50.12
Penumbra (PEN) United States $6.038B 196.53
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Globus Medical (GMED) United States $5.609B 34.61
Integra LifeSciences Holdings (IART) United States $5.276B 22.67
Elekta AB (EKTAY) Sweden $4.749B 36.56
LivaNova (LIVN) United Kingdom $4.019B 28.93
Wright Medical Group (WMGI) Netherlands $3.788B 229.62
Tandem Diabetes Care (TNDM) United States $3.767B 0.00
Nevro (NVRO) United States $3.499B 0.00
Cantel Medical (CMD) United States $3.322B 32.92
Integer Holdings (ITGR) United States $2.502B 17.13
Nihon Kohden (NHNKY) Japan $2.419B 24.34
Glaukos (GKOS) United States $2.170B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.613B 31.75
Inogen (INGN) United States $1.596B 50.40
Veracyte (VCYT) United States $1.384B 0.00
Tactile Systems Technology (TCMD) United States $1.198B 136.85
OPKO Health (OPK) United States $1.092B 0.00
Silk Road Medical (SILK) United States $1.078B 0.00
Natus Medical (NTUS) United States $1.077B 25.90
Mesa Laboratories (MLAB) United States $1.071B 39.68
Luminex (LMNX) United States $0.924B 0.00
CryoLife (CRY) United States $0.917B 94.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.857B 28.46
Accelerate Diagnostics (AXDX) United States $0.811B 0.00
Pacific Biosciences Of California (PACB) United States $0.786B 0.00
Intersect ENT (XENT) United States $0.673B 0.00
AxoGen (AXGN) United States $0.641B 0.00
Quotient (QTNT) Switzerland $0.597B 0.00
AngioDynamics (ANGO) United States $0.571B 20.53
OrthoPediatrics (KIDS) United States $0.568B 0.00
Si-Bone (SIBN) United States $0.445B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.437B 13.21
Alphatec Holdings (ATEC) United States $0.423B 0.00
Sientra (SIEN) United States $0.422B 0.00
ViewRay (VRAY) United States $0.406B 0.00
GenMark Diagnostics (GNMK) United States $0.321B 0.00
Stereotaxis (STXS) United States $0.294B 0.00
Semler Scientific (SMLR) United States $0.281B 39.08
IRadimed (IRMD) United States $0.256B 35.94
SeaSpine Holdings (SPNE) United States $0.248B 0.00
Accuray (ARAY) United States $0.246B 0.00
CRH Medical (CRHM) Canada $0.230B 64.20
Fluidigm (FLDM) United States $0.179B 0.00
EDAP TMS S.A (EDAP) France $0.151B 40.00
RTI Surgical (RTIX) United States $0.139B 37.60
ConforMIS (CFMS) United States $0.118B 0.00
Spectral Diagnostics (EDTXF) Canada $0.109B 0.00
Second Sight Medical Products (EYES) United States $0.103B 0.00
Restoration Robotics (VERO) Canada $0.088B 0.00
Neuronetics (STIM) United States $0.084B 0.00
Electromed (ELMD) United States $0.083B 29.61
Sensus Healthcare (SRTS) United States $0.063B 0.00
T2 Biosystems (TTOO) United States $0.057B 0.00
Apollo Endosurgery (APEN) United States $0.057B 0.00
TransEnterix (TRXC) United States $0.049B 0.00
Bioanalytical Systems (BASI) United States $0.047B 0.00
Ekso Bionics Holdings (EKSO) United States $0.041B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.037B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Xtant Medical Holdings (XTNT) United States $0.022B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
DarioHealth (DRIO) Israel $0.019B 0.00
Ra Medical Systems (RMED) United States $0.018B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.017B 0.00
Helius Medical Technologies (HSDT) United States $0.016B 0.00
Avinger (AVGR) United States $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.75
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Lianluo Smart (LLIT) China $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
Sunshine Heart Inc (CHFS) United States $0.003B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00